AI assistant
Sending…
MANNKIND CORP — Director's Dealing 2022
Aug 24, 2022
31835_dirs_2022-08-23_0536c7ec-3529-469d-ae9a-3ace0d4da1e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2022-08-22
Reporting Person: Galindo Alejandro (EVP Endocrine Business Unit)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-22 | Common Stock, $0.01 Par Value | S | 4600 | $3.8507 | Disposed | 777090 | Direct |
| 2022-08-22 | Common Stock, $0.01 Par Value | S | 15 | $3.84 | Disposed | 777075 | Direct |
More from MANNKIND CORP
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 26
Director's Dealing
2026
Mar 26